X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (26076) 26076
Newsletter (460) 460
Book Chapter (94) 94
Magazine Article (85) 85
Book / eBook (82) 82
Web Resource (26) 26
Dissertation (21) 21
Reference (20) 20
Conference Proceeding (15) 15
Newspaper Article (10) 10
Publication (9) 9
Transcript (6) 6
Book Review (5) 5
Journal / eJournal (2) 2
Report (2) 2
Government Document (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17701) 17701
male (13209) 13209
pharmacology & pharmacy (12793) 12793
psychiatry (10161) 10161
antipsychotic agents - therapeutic use (9575) 9575
schizophrenia (9483) 9483
antipsychotic agents - pharmacology (9339) 9339
female (9091) 9091
animals (8583) 8583
adult (7382) 7382
schizophrenia - drug therapy (7129) 7129
antipsychotic agents - adverse effects (6472) 6472
neurosciences (6201) 6201
middle aged (5111) 5111
rats (5091) 5091
antipsychotic drugs (3828) 3828
clinical neurology (3683) 3683
clozapine (3501) 3501
antipsychotic agents - administration & dosage (3463) 3463
antipsychotics (3103) 3103
risperidone (3097) 3097
haloperidol (3088) 3088
olanzapine (3032) 3032
dose-response relationship, drug (2844) 2844
double-blind (2653) 2653
adolescent (2574) 2574
aged (2548) 2548
treatment outcome (2536) 2536
drugs (2246) 2246
atypical antipsychotics (2136) 2136
dopamine (2111) 2111
neuroleptics (2069) 2069
drug therapy (2001) 2001
psychotropic drugs (1964) 1964
haloperidol - pharmacology (1941) 1941
mice (1915) 1915
psychiatric status rating scales (1813) 1813
antipsychotic agents (1735) 1735
time factors (1710) 1710
rats, sprague-dawley (1696) 1696
psychotic disorders - drug therapy (1686) 1686
clozapine - pharmacology (1572) 1572
schizophrenic psychology (1570) 1570
young adult (1563) 1563
research (1512) 1512
analysis (1506) 1506
aripiprazole (1490) 1490
bipolar disorder (1474) 1474
pharmacology (1466) 1466
antipsychotic agents - pharmacokinetics (1433) 1433
mental disorders (1426) 1426
antipsychotic (1391) 1391
drug therapy, combination (1334) 1334
risperidone - therapeutic use (1293) 1293
double-blind method (1292) 1292
antipsychotic-drugs (1284) 1284
drug interactions (1282) 1282
brain (1263) 1263
efficacy (1246) 1246
schizophrenia - physiopathology (1240) 1240
bipolar disorder - drug therapy (1230) 1230
brain - drug effects (1208) 1208
risk factors (1205) 1205
psychosis (1131) 1131
clozapine - therapeutic use (1115) 1115
pharmacology/toxicology (1111) 1111
psychopharmacology (1089) 1089
care and treatment (1085) 1085
rats, wistar (1075) 1075
antidepressants (1069) 1069
quetiapine (1056) 1056
medicine & public health (1053) 1053
brain - metabolism (1043) 1043
schizophrenia - metabolism (1031) 1031
dosage and administration (1017) 1017
child (1016) 1016
motor activity - drug effects (1012) 1012
behavior, animal - drug effects (982) 982
benzodiazepines - therapeutic use (975) 975
prefrontal cortex (975) 975
benzodiazepines (947) 947
quetiapine fumarate (944) 944
health aspects (935) 935
antipsychotic agents - blood (911) 911
dopamine - metabolism (904) 904
disease models, animal (894) 894
serotonin (892) 892
risperidone - adverse effects (886) 886
receptors (884) 884
mental disorders - drug therapy (880) 880
retrospective studies (876) 876
pharmacokinetics (839) 839
antipsychotic agents - metabolism (834) 834
risk (828) 828
piperazines - therapeutic use (824) 824
internal medicine (811) 811
rat (807) 807
pharmacotherapy (799) 799
neurology (795) 795
clozapine - adverse effects (785) 785
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (51) 51
Online Resources - Online (27) 27
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Gerstein Science - Periodical Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Lakeridge Health Sciences - Oshawa (2) 2
Providence Healthcare - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
University College (Laidlaw) - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25996) 25996
German (302) 302
French (258) 258
Japanese (215) 215
Russian (182) 182
Spanish (62) 62
Italian (60) 60
Polish (41) 41
Chinese (29) 29
Turkish (25) 25
Hungarian (24) 24
Dutch (22) 22
Portuguese (21) 21
Czech (10) 10
Ukrainian (10) 10
Norwegian (9) 9
Danish (8) 8
Finnish (4) 4
Swedish (3) 3
Bulgarian (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Slovak (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of medicinal chemistry, ISSN 0223-5234, 2011, Volume 46, Issue 8, pp. 3179 - 3189
This review summarizes recent medicinal chemistry investigations in vitro and in vivo in search for new phenothiazines of promising biological activities. New... 
Multi-drug resistance | Antifungal | Antibacterial | Azaphenothiazines | Anticancer | Phenothiazines | DESIGN | CHEMISTRY, MEDICINAL | 10H-PHENOTHIAZINES | ANTITUMOR-ACTIVITY | ANTICANCER ACTIVITY | INHIBITION | RIBOFURANOSIDES | ANTITUBERCULAR ACTIVITY | DERIVATIVES | ANTIMICROBIAL ACTIVITY | Analgesics - pharmacology | Drug Resistance, Multiple | Humans | Bacteria - drug effects | Cell Membrane Permeability | Trypanocidal Agents - chemistry | Antifungal Agents - chemistry | Structure-Activity Relationship | Anticonvulsants - pharmacology | Antiviral Agents - chemistry | Phenothiazines - pharmacology | Anti-Bacterial Agents - chemistry | Antineoplastic Agents - pharmacology | Immunosuppressive Agents - pharmacology | Antifungal Agents - pharmacology | Rabbits | Antiviral Agents - pharmacology | Anti-Inflammatory Agents - pharmacology | Solubility | Rats | Viruses - drug effects | Antineoplastic Agents - chemistry | Antimalarials - pharmacology | Animals | Anti-Inflammatory Agents - chemistry | Antipsychotic Agents - chemistry | Phenothiazines - chemistry | Trypanocidal Agents - pharmacology | Analgesics - chemistry | Anticonvulsants - chemistry | Antimalarials - chemistry | Hydrophobic and Hydrophilic Interactions | Anti-Bacterial Agents - pharmacology | Mice | Antipsychotic Agents - pharmacology | Immunosuppressive Agents - chemistry
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 2018, Volume 23, Issue 1, p. 134
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 02/2005, Volume 25, Issue 8, pp. 2157 - 2165
Regulator of G-protein signaling 9-2 (RGS9-2), a member of the RGS family of G GTPase accelerating proteins, is expressed specifically in the striatum, which... 
DEP domain | Striatum | Antipsychotic | RGS9 | dopamine receptor | Dyskinesia | Antipsychotic Agents - toxicity | RGS Proteins - genetics | Reserpine - toxicity | Sulpiride - pharmacology | Antiparkinson Agents - pharmacology | Dyskinesia, Drug-Induced - physiopathology | Humans | Recombinant Fusion Proteins - physiology | Antiparkinson Agents - toxicity | RGS Proteins - physiology | Dopamine Agents - therapeutic use | Receptors, Dopamine D2 - metabolism | Antiparkinson Agents - therapeutic use | Transfection | Apomorphine - pharmacology | Dopamine - physiology | Dopamine Agents - pharmacology | RGS Proteins - deficiency | Dopamine Antagonists - toxicity | Reserpine - pharmacology | Female | Haloperidol - pharmacology | Receptors, G-Protein-Coupled - physiology | Protein Structure, Tertiary | Corpus Striatum - physiopathology | Parkinson Disease - physiopathology | Receptors, Dopamine D2 - genetics | Mice, Knockout | Protein Interaction Mapping | Patch-Clamp Techniques | Animals | Movement Disorders - physiopathology | Dopamine Antagonists - pharmacology | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology | Corpus Striatum - drug effects | Mice | Quinpirole - pharmacology | Antipsychotic Agents - pharmacology | Movement Disorders - genetics | Haloperidol - toxicity | Subcellular Fractions - chemistry | Receptors, Dopamine D1 - genetics | striatum | Neurobiology of Disease | antipsychotic | dyskinesia | D2 dopamine receptor
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 06/2000, Volume 20, Issue 11, pp. 4030 - 4036
Journal Article
Neuropsychopharmacology (New York, N.Y.), ISSN 0893-133X, 01/2014, Volume 39, Issue 1, pp. 131 - 155
There is serious interest in understanding the dynamics of the receptor-receptor and receptor-protein interactions in space and time and their integration in... 
receptorreceptor interactions | moonlighting | neuropsychiatric disorders | G protein-coupled receptors | neurotherapeutic targets | heterodimerization | PSYCHIATRY | RESONANCE ENERGY-TRANSFER | FIBROBLAST-GROWTH-FACTOR | NEUROSCIENCES | INDUCED MOTOR COMPLICATIONS | receptor-receptor interactions | ADENOSINE A(2A) RECEPTORS | DOPAMINE D2 RECEPTORS | HIGHER-ORDER OLIGOMERS | ANTIPSYCHOTIC-DRUGS | PHARMACOLOGY & PHARMACY | CENTRAL-NERVOUS-SYSTEM | PARKINSONS-DISEASE | MOLECULAR-MECHANISMS | Schizophrenia - metabolism | Antiparkinson Agents - pharmacology | Receptors, G-Protein-Coupled - metabolism | Humans | Drug Discovery - methods | Parkinson Disease - drug therapy | Antidepressive Agents - therapeutic use | Antiparkinson Agents - therapeutic use | Cocaine - pharmacology | Depression - drug therapy | Protein Interaction Mapping - methods | Depression - metabolism | Animals | Cocaine-Related Disorders - metabolism | Antipsychotic Agents - therapeutic use | Antidepressive Agents - pharmacology | Cocaine-Related Disorders - drug therapy | Parkinson Disease - metabolism | Antipsychotic Agents - pharmacology | Schizophrenia - drug therapy | Cocaine - adverse effects | Molecular Targeted Therapy - methods | Allosteric properties | receptor–receptor interactions | Receptor Pharmacology | Dopamine | Development | Neuropharmacology | Drug Discovery | Neuropsychopharmacology Reviews
Journal Article
Psychopharmacology, ISSN 0033-3158, 1/2017, Volume 234, Issue 2, pp. 211 - 222
Journal Article
Journal Article
Psychopharmacology (Berlin, Germany), ISSN 1432-2072, 2016, Volume 234, Issue 4, pp. 525 - 533
Addition of low doses of atypical antipsychotic drugs with selective serotonin reuptake inhibitors (SSRIs) could promote a rapid antidepressant effect in... 
SSRI | Neurosciences | Biomedicine | Fluoxetine | Spine | Brexpiprazole | Inflammation | Pharmacology/Toxicology | Psychiatry | PSYCHIATRY | ADJUNCTIVE BREXPIPRAZOLE | INADEQUATE RESPONSE | ARIPIPRAZOLE AUGMENTATION | NEUROTROPHIC FACTOR BDNF | NECROSIS-FACTOR-ALPHA | DOPAMINE ACTIVITY MODULATOR | NEUROSCIENCES | SEROTONIN 5-HT1A | SERUM-LEVELS | DOUBLE-BLIND | DISORDER | PHARMACOLOGY & PHARMACY | Thiophenes - therapeutic use | Male | Dendritic Spines - metabolism | Quinolones - pharmacology | Depression - drug therapy | Depression - metabolism | Inflammation - metabolism | Prefrontal Cortex - drug effects | Antipsychotic Agents - therapeutic use | Dendritic Spines - drug effects | Inflammation - drug therapy | Quinolones - therapeutic use | Behavior, Animal - drug effects | Antidepressive Agents - pharmacology | Brain-Derived Neurotrophic Factor - metabolism | Neurons - metabolism | Fluoxetine - therapeutic use | Neurons - drug effects | Fluoxetine - pharmacology | Thiophenes - pharmacology | Antidepressive Agents - therapeutic use | Animals | Signal Transduction - drug effects | Prefrontal Cortex - metabolism | Mice | Antipsychotic Agents - pharmacology | Antidepressants | Dosage and administration | Drug therapy, Combination | Drug therapy | Methods | Major depressive disorder | Studies | Psychopharmacology | Analysis | Original Investigation
Journal Article
Brain Research, ISSN 0006-8993, 2008, Volume 1211, pp. 37 - 43
Journal Article
Brain research, ISSN 0006-8993, 2017, Volume 1660, pp. 58 - 66
Journal Article